Understanding in 2 Minutes: Charcot's Disease (ALS)

François SALACHAS, neurologist (Sorbonne University - APHP) and coordinator of the iCRIN SLA of Paris Brain Institute, explains the causes, symptoms and treatments of Charcot’s disease (SLA).

Pour en savoir plus sur la maladie de Charcot (SLA)

La maladie de Charcot (SLA)

La Sclérose Latérale Amyotrophique (SLA) ou « Maladie de Charcot » est une pathologie neuromusculaire progressive et fatale caractérisée par la mort progressive des neurones moteurs, neurones qui commandent entre autres la marche, la parole, la...

News that might interest you

Invincibles ensemble!: the growing success of a solidarity concert for ALS research

On Wednesday 15 October 2025, the mythical stage of the Olympia hosted the concert “Invincibles ensemble!” for its second edition. Twenty artists have mobilized to fight amyotrophic lateral sclerosis (ALS), also known as Charcot’s disease.

10.16.2025 Support

"La Généreuse" a solidarity regatta for ALS research

The association La Généreuse, founded by Laurent de Bernède, has the mission of raising funds to support charitable causes by organising sporting and cultural events. In 2025, she wanted to join Olivier Goy’s fight for ALS research at Paris Brain...

09.22.2025 Support

Looking back at the “Brain to Market” Summer School 2024 dedicated to motor neurone disease

From September 9 to 13, the Open Brain School, the education center at Paris Brain Institute, organized the 10th edition of its flagship training program in neuroscience and entrepreneurship—dedicated to fostering innovation. This event brought the...

10.07.2024 Teaching & training

Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.

Ultrasound show unexpected effects on motor neuron disease

Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...

09.05.2024 Research, science & health

Discovery of a plasma signature of fronto-temporal degeneration and amyotrophic lateral sclerosis linked to a mutation of the C9orf72 gene

A joint study by teams from the Paris Brain Institute at the Pitié-Salpêtrière hospital and from Inria (Rennes and Paris centers) has revealed for the first-time plasma microRNA signatures in individuals with or presymptomatic of fronto-temporal...

12.04.2020 Research, science & health

A promising therapeutic approach in amyotrophic lateral sclerosis (ALS)

Paris, October 19th, 2020 - ALS is characterized by the degeneration of motor neurons resulting in a progressive and irreversible deficit in walking and speech, until a complete paralysis of all muscles, including those controlling respiration. The...

10.20.2020 Research, science & health

See all our news